Procedure
HAIC-FOLFOX
HAIC-FOLFOX is a medical procedure with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph phase_2
3
100%
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
3(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Other(2)
Detailed Status
unknown2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 23 (100.0%)
Trials by Status
unknown267%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_2
PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC
NCT06742424
unknownphase_2
Sintilimab Combined With Lenvatinib Versus HAIC for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma
NCT05519410
unknownphase_2
HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC
NCT05493332
Clinical Trials (3)
Showing 3 of 3 trials
NCT06742424Phase 2
PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC
NCT05519410Phase 2
Sintilimab Combined With Lenvatinib Versus HAIC for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma
NCT05493332Phase 2
HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC
All 3 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 3